Transforming Alzheimer’s Disease and Related Dementia Research: New Core Digital Clinical Measures
Date/Time
November 14, 2024
Panelists
Moderator
Discussion Topic
Alzheimer’s disease and related dementias (collectively referred to as ADRD) have become a public health epidemic. Globally, ADRD affects 47 million people and the expected growth is staggering, with cases expected to double every 20 years.
Even with the increased number of ADRD cases, progress in using digital technologies in clinical research has been limited, and there’s been very little work done to understand meaningful aspects of health for people with ADRD and care partners.
DATAcc by DiMe, with the inclusive group of global multistakeholder experts, has developed a core set of digital measures for ADRD—a set of patient-centered digital measures that bring together research and treatment innovation and the real-world needs of patients, care partners, and clinicians. These measures focus on what truly matters to people living with ADRD and their care partners, ensuring that clinical trials are designed to reach outcomes that reflect meaningful and tangible benefits.
